Akira Kawamura to Atherosclerosis
This is a "connection" page, showing publications Akira Kawamura has written about Atherosclerosis.
Connection Strength
0.309
-
Suematsu Y, Kawachi E, Idemoto Y, Matsuo Y, Kuwano T, Kitajima K, Imaizumi S, Kawamura A, Saku K, Uehara Y, Miura SI. Anti-atherosclerotic effects of an improved apolipoprotein A-I mimetic peptide. Int J Cardiol. 2019 12 15; 297:111-117.
Score: 0.160
-
Kawamura A, Baitsch D, Telgmann R, Feuerborn R, Weissen-Plenz G, Hagedorn C, Saku K, Brand-Herrmann SM, von Eckardstein A, Assmann G, Nofer JR. Apolipoprotein E interrupts interleukin-1beta signaling in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2007 Jul; 27(7):1610-7.
Score: 0.068
-
Matsuo Y, Miura S, Kawamura A, Uehara Y, Rye KA, Saku K. Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation. Atherosclerosis. 2007 Sep; 194(1):159-68.
Score: 0.066
-
Miura S, Matsuo Y, Kawamura A, Saku K. JTT-705 blocks cell proliferation and angiogenesis through p38 kinase/p27(kip1) and Ras/p21(waf1) pathways. Atherosclerosis. 2005 Oct; 182(2):267-75.
Score: 0.015